primary hypertension
Conditions
Interventions
Exposure group (Treatment of patients with primary hypertension using Angong Jiangya Pill):NA
Non exposed group (Patients with primary hypertension treated only with conventional Western medicine antihypertensive drugs):NA
Sponsors
The Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Consistent with the diagnosis of primary hypertension in Western medicine or the diagnosis of liver yang hyperactivity in traditional Chinese medicine vertigo; (2) The patient is = 18 years old, regardless of gender; (3) Patients who visited between January 2018 and December 2022 and have at least one follow-up record; (4) No Angong Jiangya Pill or traditional Chinese patent medicines and simple preparations similar to Angong Jiangya Pill (such as Naoliqing Pill, Qingnao Jiangya Tablet, Niuhuang Jiangya Pill, etc.) was taken at least one month before the observation.
Exclusion criteria
Exclusion criteria: (1) During the observation period, traditional Chinese patent medicines and simple preparations (such as Naoliqing Pill, Qingnao Jiangya Tablet, Niuhuang Jiangya Pill, etc.) with similar effects to Angong Jiangya Pill were taken; (2) Patients with secondary hypertension; (3) Concomitant with severe primary diseases such as heart, liver, and kidney; (4)The case data is incomplete, and the main observation indicators are severely missing.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinic blood pressure;Symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Dynamic blood pressure; | — |
Countries
China
Contacts
Public ContactTang Qisheng
The Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine
Outcome results
None listed